Moreover, DSS-treated mice administered concurrently with l-clodronate show milder clinical symptoms of colitis, intestinal transit times similar to control animals, and decreased expression of factors implicated in neural inflammation and death, including Bax, Hdac4, IL-18, Casp8 and Hif1a. Here, HIF1A is linked to colitis.